Quantitative imaging of low-yield therapeutic emitters
48No. 751 in all physics · No. 34 in Medical and Radiation Physics
Achieve activity quantification to better than 10 percent for therapeutic nuclides with sparse or complex photon emission, notably Ac-225 at administered activities of order 2.7 microCi per kg (about 0.2 mCi per patient), imaged through the daughter gamma lines at 218 keV (Fr-221) and 440 keV (Bi-213), and Pb-212 at 239 keV, including scatter, collimator septal penetration and partial-volume correction. An answer is a calibrated imaging and reconstruction protocol with measured accuracy.
What would settle it
Phantom and patient measurements with independent activity ground truth demonstrating the stated accuracy.
No solutions, ideas or subproblems yet.
See also
- Related Forward model for charge sharing and pulse pileup
- Related Does absorbed dose predict outcome in radionuclide therapy?
Details, signature and history
- Kind
- Well-posed question
- Answer
- Value
- Posed
- 2015
- Topic review
- Sgouros, Bodei, McDevitt and Nedrow, Radiopharmaceutical therapy in cancer: clinical advances and challenges, Nature Reviews Drug Discovery, 2020. Link
- Record
- Revision 1 · imported from the seed collection · compiled by AI, not yet reviewed by an editor
Proof
- Fingerprint
- 4335bf823ded…
- Public log
- Entry 1,723, in checkpoint 2,123
- In the log by
- Block 969,698, 2026-10-03
This text was in the PubPhys log by that date. The date says nothing about when the problem was first posed.
Comments (0)
Comments are not records: they are not signed, stamped or logged. How comments work
No comments yet.
Sign in to comment.